267 related articles for article (PubMed ID: 25893411)
1. Photoimmunotherapy Inhibits Tumor Recurrence After Surgical Resection on a Pancreatic Cancer Patient-Derived Orthotopic Xenograft (PDOX) Nude Mouse Model.
Hiroshima Y; Maawy A; Zhang Y; Guzman MG; Heim R; Makings L; Luiken GA; Kobayashi H; Tanaka K; Endo I; Hoffman RM; Bouvet M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1469-74. PubMed ID: 25893411
[TBL] [Abstract][Full Text] [Related]
2. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
[TBL] [Abstract][Full Text] [Related]
3. Near infra-red photoimmunotherapy with anti-CEA-IR700 results in extensive tumor lysis and a significant decrease in tumor burden in orthotopic mouse models of pancreatic cancer.
Maawy AA; Hiroshima Y; Zhang Y; Heim R; Makings L; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
PLoS One; 2015; 10(3):e0121989. PubMed ID: 25799218
[TBL] [Abstract][Full Text] [Related]
4. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
[TBL] [Abstract][Full Text] [Related]
6. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
[TBL] [Abstract][Full Text] [Related]
7. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
[TBL] [Abstract][Full Text] [Related]
8. Improved micro-distribution of antibody-photon absorber conjugates after initial near infrared photoimmunotherapy (NIR-PIT).
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Kobayashi H
J Control Release; 2016 Jun; 232():1-8. PubMed ID: 27059723
[TBL] [Abstract][Full Text] [Related]
9. Near-infrared photoimmunotherapy of pancreatic cancer using an indocyanine green-labeled anti-tissue factor antibody.
Aung W; Tsuji AB; Sugyo A; Takashima H; Yasunaga M; Matsumura Y; Higashi T
World J Gastroenterol; 2018 Dec; 24(48):5491-5504. PubMed ID: 30622378
[TBL] [Abstract][Full Text] [Related]
10. Combination photoimmunotherapy with monoclonal antibodies recognizing different epitopes of human epidermal growth factor receptor 2: an assessment of phototherapeutic effect based on fluorescence molecular imaging.
Ito K; Mitsunaga M; Nishimura T; Kobayashi H; Tajiri H
Oncotarget; 2016 Mar; 7(12):14143-52. PubMed ID: 26909859
[TBL] [Abstract][Full Text] [Related]
11. Photoimmunotherapy: comparative effectiveness of two monoclonal antibodies targeting the epidermal growth factor receptor.
Sato K; Watanabe R; Hanaoka H; Harada T; Nakajima T; Kim I; Paik CH; Choyke PL; Kobayashi H
Mol Oncol; 2014 May; 8(3):620-32. PubMed ID: 24508062
[TBL] [Abstract][Full Text] [Related]
12. Cadherin-17 Targeted Near-Infrared Photoimmunotherapy for Treatment of Gastrointestinal Cancer.
Lum YL; Luk JM; Staunton DE; Ng DKP; Fong WP
Mol Pharm; 2020 Oct; 17(10):3941-3951. PubMed ID: 32931292
[TBL] [Abstract][Full Text] [Related]
13. Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model.
Metildi CA; Kaushal S; Luiken GA; Talamini MA; Hoffman RM; Bouvet M
J Surg Oncol; 2014 Apr; 109(5):451-8. PubMed ID: 24249594
[TBL] [Abstract][Full Text] [Related]
14. Photoimmunotherapy of residual disease after incomplete surgical resection in head and neck cancer models.
Moore LS; de Boer E; Warram JM; Tucker MD; Carroll WR; Korb ML; Brandwein-Gensler MS; van Dam GM; Rosenthal EL
Cancer Med; 2016 Jul; 5(7):1526-34. PubMed ID: 27167827
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Early Therapeutic Effects after Near-Infrared Photoimmunotherapy (NIR-PIT) Using Luciferase-Luciferin Photon-Counting and Fluorescence Imaging.
Maruoka Y; Nagaya T; Nakamura Y; Sato K; Ogata F; Okuyama S; Choyke PL; Kobayashi H
Mol Pharm; 2017 Dec; 14(12):4628-4635. PubMed ID: 29135265
[TBL] [Abstract][Full Text] [Related]
16. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
[TBL] [Abstract][Full Text] [Related]
17. CD47-Targeted Near-Infrared Photoimmunotherapy for Human Bladder Cancer.
Kiss B; van den Berg NS; Ertsey R; McKenna K; Mach KE; Zhang CA; Volkmer JP; Weissman IL; Rosenthal EL; Liao JC
Clin Cancer Res; 2019 Jun; 25(12):3561-3571. PubMed ID: 30890547
[TBL] [Abstract][Full Text] [Related]
18. Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice.
Hiroshima Y; Maawy A; Sato S; Murakami T; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
J Surg Res; 2014 Apr; 187(2):510-7. PubMed ID: 24373959
[TBL] [Abstract][Full Text] [Related]
19. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
[TBL] [Abstract][Full Text] [Related]
20. Cancer cell-selective in vivo near infrared photoimmunotherapy targeting specific membrane molecules.
Mitsunaga M; Ogawa M; Kosaka N; Rosenblum LT; Choyke PL; Kobayashi H
Nat Med; 2011 Nov; 17(12):1685-91. PubMed ID: 22057348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
